てんかん(癲癇):世界医薬品市場予測及び市場分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 21
2.1 Catalyst 21
2.2 Upcoming Related Reports 22
3 Disease Overview 23
3.1 Classification of Seizures 25
3.2 Etiology and Pathophysiology 26
3.2.1 Etiology 26
3.2.2 Pathophysiology 29
3.2.3 Prognosis 34
3.2.4 Quality of Life 35
4 Epidemiology 36
4.1 Risk Factors and Comorbidities 36
4.1.1 Risk factors in newborns often include brain malformations and lack of oxygen 36
4.1.2 Genetic factors and head trauma are risk factors in adults and children 36
4.1.3 Common seizure triggers include lack of sleep, stress, and photosensitivity 37
4.1.4 Epilepsy comorbidities in adults and children include pain disorders 37
4.1.5 Anxiety and depression are major epilepsy comorbidities 37
4.1.6 Epilepsy with a known cause can be prevented by the avoidance of head injuries 38
4.2 Global Trends 38
4.2.1 United States 39
4.2.2 5EU Markets (France, Germany, Italy, Spain, and the UK) 40
4.2.3 Asia 41
4.3 Forecast Methodology 43
4.3.1 Sources Used 44
4.3.2 Forecast Assumptions and Methods 49
4.3.3 Sources Not Used 51
4.4 Epidemiologic Forecast 52
4.4.1 Total Active Prevalent Cases of Epilepsy 52
4.4.2 Total Lifetime Prevalent Cases of Epilepsy 54
4.4.3 Age-Specific Total Active Prevalent Cases of Epilepsy 56
4.4.4 Gender-Specific Total Active Prevalent Cases of Epilepsy 57
4.4.5 Seizure-Specific Total Active Prevalent Cases of Epilepsy 58
4.5 Discussion 59
4.5.1 Conclusion on Epidemiological Trends 59
4.5.2 Limitations of the Analysis 60
4.5.3 Strengths of the Analysis 60
5 Disease Management 61
5.1 Diagnosis 61
5.2 Treatment Guidelines 62
5.3 Clinical Practice 63
5.4 US 69
5.4.1 Diagnosis 69
5.4.2 Clinical Practice 71
5.5 UK 74
5.5.1 Diagnosis 74
5.5.2 Clinical Practice 75
5.6 France 76
5.6.1 Diagnosis 76
5.6.2 Clinical Practice 77
5.7 Germany 78
5.7.1 Diagnosis 78
5.7.2 Clinical Practice 79
5.8 Spain 81
5.8.1 Diagnosis 81
5.8.2 Clinical Practice 82
5.9 Italy 83
5.9.1 Diagnosis 83
5.9.2 Clinical Practice 84
5.10 Japan 85
5.10.1 Diagnosis 85
5.10.2 Clinical Practice 86
5.11 India 87
5.11.1 Diagnosis 87
5.11.2 Clinical Practice 87
5.12 China 89
5.12.1 Diagnosis 89
5.12.2 Clinical Practice 91
6 Competitive Assessment 93
6.1 Overview 93
6.2 Strategic Competitor Assessment 94
6.3 Product Profiles – Major Brands 97
6.3.1 Keppra (levetiracetam) 97
6.3.2 Lamictal (lamotrigine) 102
6.3.3 Lyrica (pregabalin) 107
6.3.4 Vimpat (lacosamide) 111
6.3.5 Zonegran (zonisamide) 115
6.3.6 Banzel/Inovelon (rufinamide) 120
6.3.7 Trobalt/Potiga (retigabine/ezogabine) 124
6.3.8 Zebinix (eslicarbazepine acetate) 127
6.3.9 Fycompa (perampanel) 131
6.3.10 Older-Generation AEDs 134
7 Opportunity and Unmet Need 136
7.1 Overview 136
7.2 Unmet Needs 137
7.2.1 Refractory Epilepsy 137
7.2.2 Safety/Side Effect Profiles 137
7.2.3 Curative/Disease-Modifying Agents 138
7.2.4 Predictive Tools and Need for More Directed Treatments 139
7.2.5 Improved Preclinical Models and Clinical Trial Paradigms 139
7.2.6 Treatment Gap 140
7.3 Unmet Needs Gap Analysis 141
7.4 Opportunities 142
7.4.1 Disease-Modifying Agents 142
7.4.2 Improved Preclinical Models and Clinical Trial Paradigms 142
7.4.3 Treatment Gap 142
8 Pipeline Assessment 143
8.1 Overview 143
8.2 Clinical Trial Mapping 143
8.2.1 Clinical Trials by Country 143
8.3 Clinical Trials by Phase and Trial Status 145
8.4 Strategic Pipeline Assessment 146
8.5 Pipeline by Phases of Development 147
8.5.1 Phase III Pipeline 147
8.5.2 Phase III Pipeline – Reformulations/New Delivery Systems 148
8.5.3 Phase IIb Pipeline 148
8.5.4 Phase II Pipeline 149
8.5.5 Phase I Pipeline 149
8.5.6 Preclinical Pipeline 150
8.5.7 Discovery Pipeline 151
8.6 Pipeline by Mechanism of Action 151
8.7 Promising Drugs in Clinical Development 153
8.7.1 Brivaracetam 154
8.7.2 Ganaxolone 157
8.7.3 VX-765 161
9 Current and Future Players 165
9.1 Overview 165
9.2 Trends in Corporate Strategy 168
9.3 Company Profiles 169
9.3.1 UCB 169
9.3.2 Eisai 171
9.3.3 Pfizer 172
9.3.4 GlaxoSmithKline 174
9.3.5 Novartis 175
9.3.6 Abbott 177
9.3.7 Dainippon Sumitomo Pharma 179
10 Market Outlook 181
10.1 Global Markets 181
10.1.1 Forecast 181
10.1.2 Drivers and Barriers – Global Issues 184
10.2 United States 186
10.2.1 Forecast 186
10.2.2 Key Events 189
10.2.3 Drivers and Barriers 189
10.3 France 191
10.3.1 Forecast 191
10.3.2 Key Events 194
10.3.3 Drivers and Barriers 194
10.4 Germany 195
10.4.1 Forecast 195
10.4.2 Key Events 199
10.4.3 Drivers and Barriers 199
10.5 Italy 201
10.5.1 Forecast 201
10.5.2 Key Events 204
10.5.3 Drivers and Barriers 204
10.6 Spain 206
10.6.1 Forecast 206
10.6.2 Key Events 209
10.6.3 Drivers and Barriers 209
10.7 United Kingdom 210
10.7.1 Forecast 210
10.7.2 Key Events 214
10.7.3 Drivers and Barriers 214
10.8 Japan 216
10.8.1 Forecast 216
10.8.2 Key Events 219
10.8.3 Drivers and Barriers 219
10.9 India 221
10.9.1 Forecast 221
10.9.2 Key Events 224
10.9.3 Drivers and Barriers 224
10.10 China 226
10.10.1 Forecast 226
10.10.2 Key Events 229
10.10.3 Drivers and Barriers 229
11 Appendix 231
11.1 Bibliography 231
11.2 Abbreviations 244
11.3 Methodology 247
11.4 Forecasting Methodology 247
11.4.1 Prevalent Epilepsy Patients 247
11.4.2 Percent Drug-Treated Patients 248
11.4.3 Drugs Included in Each Therapeutic Class Based on MOA 248
11.4.4 Launch Dates and Patent and Market Exclusivity Expiry Dates 249
11.4.5 General Pricing Assumptions 251
11.4.6 Individual Drug Assumptions 252
11.4.7 Generic Erosion 266
11.4.8 Pricing of Pipeline Agents 266
11.5 Physicians and Specialists Included in this Study 267
11.6 Primary Research – Prescriber Survey 268
11.7 About the Authors 269
11.7.1 Authors 269
11.7.2 Epidemiologist 270
11.7.3 Global Head of Healthcare 270
11.8 About GlobalData 271
11.9 Contact Us 271
11.10 Disclaimer 271


【レポート販売概要】

■ タイトル:てんかん(癲癇):世界医薬品市場予測及び市場分析
■ 英文:PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis
■ 発行日:2013年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160308
■ 調査対象地域:グローバル
  • PGNiG SA:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    PGNiG SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary PGNiG SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, …
  • 胃不全麻痺治療薬の世界市場
    ABSTRACTAbout Gastroparesis Drugs Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract. Normally, the vagus nerve controls the stomach muscles, which are responsible for the movement of food in the stomach. These muscles contract to break up the food and lead to its movement through the gastrointestinal tract. Gast …
  • 二輪車用無段変速機の世界市場2016-2020
    About Continuously Variable Transmission Market for Two-Wheelers CVT in two-wheelers is generally used in the scooter segment. Almost all scooters are now equipped with CVT whereas most of the motorbikes are equipped with manual transmission technology. Unlike manual transmission, CVT does not have gear shift but instead has infinite gear ratios, whose transition takes place almost seamlessly with …
  • 燃料添加剤(ディーゼル、ガソリン、航空用)のグローバル市場
    Lubricant additives can be categorized into ten major types based on their functions, which are dispersants, viscosity index improvers, detergents, antiwear, antioxidants, corrosion inhibitors, emulsifiers, friction modifiers, EP, PPDs, and others. These are made of raw material/ chemicals such as poly amines, phenols, olefin, maleic anhydride, and others. Lubricant additives find their usage in v …
  • 世界の位置情報基盤の検索・広告市場動向(2012-2016)
    TechNavio's analysts forecast the Global Location-based Search and Advertising market to grow at a CAGR of 49.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing use of location-based application-enabled mobile media. The Global Location-based Search and Advertising market has also been witnessing the increasing adoption of location-bas …
  • 薬剤溶出ステントのグローバル製品パイプライン動向2015
    Drug Eluting Stents (DES) - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Drug Eluting Stents (DES) - Pipeline Review, 2015" provides an overview of Drug Eluting Stents currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major p …
  • 世界の穀物保護用化学品市場
    The global crop protection market consists of crop protection chemicals or agrochemicals, seeds, and genetically modified (GM) crops. Crop protection chemicals are the most dominating segment of this market in terms of market share as well as product innovations. Crop protection chemicals are further classified as herbicides, insecticides, fungicides, bio-pesticides, and adjuvants. As the latter t …
  • 世界のタッチコントローラIC市場動向(2012-2016)
    TechNavio's analysts forecast the Global Touch Controller IC market to grow at a CAGR of 31.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablets. The Global Touch Controller IC market has also been witnessing increasing penetration in the Healthcare Equipment sector. However, the increasing cost of prod …
  • 貿易管理の世界市場予測(~2022年):ソリューション、サービス
    The global trade management market is expected to grow from USD 645.2 Million in 2017 to USD 1,034.2 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 9.9%. Several factors such as increasing complexities in global trade, changing government rules and regulations pertaining to foreign trade, increasing transportation costs, and increasing investment in global logisitics infrastructure ar …
  • 世界の研究室/ラボ用電子天びん市場(2014-2018)
    About Laboratory Electronic Balance An electronic balance is an essential instrument for any modern science laboratory as it helps in the precise weighing of materials. It can be broadly classified into two types: top loading balance and analytical balance. TechNavio's analysts forecast the Global Laboratory Electronic Balance market to grow at a CAGR of 4.52 percent over the period 2013-2018. Cov …
  • 通信キャリアのモバイルコマース戦略:Mobile Commerce Carrier Strategies
    Mobile Commerce is both an opportunity and a threat to carriers as many third parties seek to offer alternatives to network operator based offerings. Competitors include established players such as PayPal as well as many start-up companies. Incumbent operators face the threat of Google and other larger players that wish to dominate this large market opportunity. In addition, carriers are faced wit …
  • 世界のセイボリースナック市場:ニュース、イベント動向(2014年3月)
    Synopsis The report provides a review of the latest news and key events in the global savory snacks market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory snacks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the …
  • 局所はんだ付け装置の世界市場予測・分析2019-2023
    Global Selective Soldering Equipment Market: About this market Technavio’s selective soldering equipment market analysis considers sales from networking and communication, consumer electronics, automotive, medical, industrial, and instrumentation, and aerospace and defense in Europe, North America, South America, and MEA. In 2018, the networking and communication segment had a significant market s …
  • 衛生ベース自動船舶識別装置(S-AIS)の世界市場2016-2020
    About the Satellite Based Automatic Identification Systems (S-AIS) Market The S-AIS is a very high-frequency automatic vessel tracking system that provides location information to ships and shore stations through electronic exchange of data regarding position, identification, course, and speed. AIS enables two-way communication between coastal authorities and several vessels using satellite commun …
  • ボトル入り湧水の世界市場2017-2021
    About Bottled Spring WaterThe spring water originates from an underground source from which water naturally rises to the surface. Spring water is found to be a natural source of minerals and is considered to be free of most contaminants typically found in the drinking water. Also, spring water helps to maintain the acidity level in the body as spring water is slightly alkaline in nature. The sprin …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。